Adipotide (FTPP) – Targeted Fat Cell Loss and Metabolic Research

What is Adipotide?

Adipotide, also known as FTPP (Proapoptotic Peptide), is an experimental research peptide aimed at targeting fat cells by blocking their blood supply. This peptide is attracting attention in scientific research for its potential to reduce fat mass by killing fat cells via apoptosis, a natural process of programmed cell death.

How does Adipotide work?

Adipotide specifically binds to the blood vessels that supply adipose tissue with oxygen and nutrients. By blocking this blood supply, the peptide causes oxygen deficiency (ischemia) in the adipose tissue, leading to fat cell death. This targeted action helps reduce fat mass without damaging surrounding tissues. This mechanism indirectly stimulates the body to break down excess fat and contributes to improved metabolic health. This effect has been extensively studied in laboratory studies.

What are the effects of Adipotide in research?

• Targeted fat cell loss: Adipotide induces apoptosis of fat cells by blocking their blood supply, resulting in reduction of fat mass in preclinical models.
• Improved metabolic parameters: Studies suggest that the peptide may have beneficial effects on metabolism, relevant to obesity research.
• Selective action: The peptide specifically targets fat tissue, without negative effects on other tissues.
• Research potential: Used in studies of metabolic health and fat mass reduction.